Early Phase Cancer Immunotherapy

This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Patel, Sandip Pravin (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Kurzrock, Razelle (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Current Cancer Research,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins
  • Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy
  • Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies
  • Chapter 4 Radiographic Evaluation of Immunotherapy
  • Chapter 5 Cellular Therapy
  • Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation
  • Chapter 7 Early Phase Cancer Immunotherapy
  • Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators
  • Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials
  • Chapter 10 Thoracic Immunotherapy.